Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-001721
Filing Date
2015-08-27
Accepted
2015-08-27 17:20:28
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20150630x10q.htm 10-Q 832058
2 EX-31.1 zyne-20150630ex311800820.htm EX-31.1 10905
3 EX-31.2 zyne-20150630ex312ac8ca3.htm EX-31.2 10695
4 EX-32.1 zyne-20150630ex32178510f.htm EX-32.1 6567
5 EX-32.2 zyne-20150630ex322b3bc5e.htm EX-32.2 6653
  Complete submission text file 0001558370-15-001721.txt   2812271

Data Files

Seq Description Document Type Size
6 EX-101.INS zyne-20150630.xml EX-101.INS 467598
7 EX-101.SCH zyne-20150630.xsd EX-101.SCH 18182
8 EX-101.CAL zyne-20150630_cal.xml EX-101.CAL 26502
9 EX-101.DEF zyne-20150630_def.xml EX-101.DEF 83914
10 EX-101.LAB zyne-20150630_lab.xml EX-101.LAB 188531
11 EX-101.PRE zyne-20150630_pre.xml EX-101.PRE 169150
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 151079535
SIC: 2834 Pharmaceutical Preparations